The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Raynor Daniel since 2005.
The trader's CIK number is 1068854.
At the time of the last reporting, Raynor Daniel was the Director of Ani Pharmaceuticals Inc. (stock ticker symbol ANIP).
Also see all insider trading activities at Ani Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | NUCO | 0 | $0 | 0 | $0 | 6,000 | $75,000 |
| 2006 | NUCO | 0 | $0 | 20,601 | $565,528 | 0 | $0 |
| 2005 | NUCO | 0 | $0 | 145,890 | $3,537,566 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ANIP | 0 | $0 | 35,179 | $2,183,452 | 0 | $0 |
| 2015 | ANIP | 0 | $0 | 200,000 | $12,600,000 | 0 | $0 |
| 2014 | ANIP | 0 | $0 | 33,458 | $1,133,396 | 0 | $0 |
2. Ani Pharmaceuticals Inc (ANIP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-02-08 | NUCO | Option Ex | 6,000 | 12.50 | 75,000 |
| 2006-08-24 | NUCO | Sale | 2,000 | 26.22 | 52,440 |
| 2006-08-25 | NUCO | Sale | 2,000 | 26.05 | 52,100 |
| 2006-08-21 | NUCO | Sale | 3,000 | 26.64 | 79,920 |
| 2006-05-22 | NUCO | Sale | 4,000 | 26.38 | 105,500 |
| 2006-05-23 | NUCO | Sale | 2,000 | 26.75 | 53,500 |
| 2006-02-23 | NUCO | Sale | 2,000 | 28.61 | 57,220 |
| 2006-02-10 | NUCO | Sale | 5,601 | 29.43 | 164,848 |
| 2005-06-28 | NUCO | Sale | 70,890 | 25.74 | 1,824,566 |
| 2005-03-30 | NUCO | Sale | 75,000 | 22.84 | 1,713,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-03-15 | ANIP | Sale | 1,902 | 61.50 | 116,973 |
| 2018-03-19 | ANIP | Sale | 5,313 | 60.62 | 322,074 |
| 2018-03-12 | ANIP | Sale | 7,928 | 62.88 | 498,512 |
| 2018-03-13 | ANIP | Sale | 18,117 | 62.20 | 1,126,877 |
| 2018-03-14 | ANIP | Sale | 1,919 | 62.02 | 119,016 |
| 2015-03-12 | ANIP | Sale | 200,000 | 63.00 | 12,600,000 |
| 2014-03-14 | ANIP | Sale | 12,347 | 33.85 | 417,945 |
| 2014-03-12 | ANIP | Sale | 21,111 | 33.89 | 715,451 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Raynor Daniel (Director of Ani Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.